Prestige Consumer Healthcare (PBH) Q3 Earnings Lag Estimates

分组1 - Prestige Consumer Healthcare reported quarterly earnings of $1.14 per share, missing the Zacks Consensus Estimate of $1.16 per share, and down from $1.22 per share a year ago, representing an earnings surprise of -1.30% [1] - The company posted revenues of $283.44 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 0.48%, but down from $290.32 million year-over-year [2] - Prestige Consumer Healthcare has surpassed consensus EPS estimates two times over the last four quarters and topped consensus revenue estimates three times in the same period [2] 分组2 - The stock has gained approximately 8.7% since the beginning of the year, outperforming the S&P 500's gain of 0.5% [3] - The current consensus EPS estimate for the coming quarter is $1.43 on revenues of $299.85 million, and for the current fiscal year, it is $4.55 on revenues of $1.11 billion [7] - The Zacks Industry Rank indicates that the Medical - Products sector is currently in the bottom 29% of over 250 Zacks industries, suggesting potential challenges for stock performance [8]